Is this your organization?Claim your profile for free to personalize your presence and add a donate button. Learn more

Start Your Claim

Claiming and managing your profile is free. Enter any email you have access to. In the next step, we'll give you a small snippet to place on the organization's website to verify ownership.

Email address

We'll use this to process your claim and send important profile updates.

Need help? Contact us

: Verified by RoundPaper

FY 2023

Verified NonprofitLast Filed 2023EIN 13-3709252

The Leukemia & Lymphoma Society Research Foundation

RYE BROOK, NYNTEE: G053Website

mission statement

The corporation was formed to support the research programs of the leukemia lymphoma society, INC.tax id# 13-5644916

Share this profile

Total Revenue

—

FY 2023

Program Spending

—

of total expenses

Known Funders

2019–2024 filings

Key Metrics (FY 2023)

The Numbers

—

Total Assets

FY 2023

Latest Filing

IRS data

Active Programs

FY 2023

Sector

NTEE G053

Funding Track Record

Backed by 27 Institutional Funders

$132K raised across 66 grants (2019–2024 filings)

Funder Geography

Funders across 13 states (2019–2024 filings)

Institutional Funding by Year

Funder	Location	Total Awarded
Georgia Community Foundation Inc	PEACHTREE CORNERS, GA	$35,000
Textron Charitable Trust Dtd 122353	PROVIDENCE, RI	$20,840
Checkers Charitable Foundation	CHARLOTTE, NC	$20,000
J Gurwin Foundation Inc	NEW YORK, NY	$10,000
Harvey and Linda Litofsky Family Foundation	BALTIMORE, MD	$9,000
Ge Foundation	NORWALK, CT	$7,645
United Food and Commercial Workers International Union	Springfield, MA	$6,000
The US Charitable Gift Trust	Boston, MA	$5,650
David and Sherry Cordani Family Foundation	WEST HARTFORD, CT	$5,000
Bristol-Myers Squibb Foundation Inc	NEW YORK, NY	$2,880

Total tracked: $132,041 across 66 grants (2019–2024 filings)

Programs (FY 2023)

What They Do

— in expenses

The leukemia & lymphoma society research foundation's program is based on the belief that all scientifically sound approaches toward a cure for, or control of leukemia, lymphoma, hodgkin's and non-hodgkin's lymphoma and myeloma should be encouraged on a worldwide basis.

Governance (FY 2023)

Leadership

Freda Wang

Secretary/Treasurer

Kathleen Meriwether

Board Vice Chair

Jeff Sachs

Board Chair

E Anders Kolb

Chief Executive Officer

Organization ExclusiveComing Soon

Your profile shows 27 known funders. We can find more.

Get a comprehensive Funder Intelligence Report with ranked prospects, fit scores, and funder briefs tailored to The Leukemia & Lymphoma Society Research Foundation.